PDB Short entry for 5BPY HEADER TRANSFERASE/TRANSFERASE INHIBITOR 28-MAY-15 5BPY TITLE CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE TITLE 2 COMPLEXED WITH BMS-824171 AKA 6-[(3R)-3-(4-TERT-BU TYLBENZAMIDO) TITLE 3 PIPERIDIN-1-YL]-2-{[4-(MORPHOLINE-4-CARBONYL) PHENYL]AMINO}PYRIDINE- TITLE 4 3-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 5 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PFASTBAC1-HM KEYWDS KINASE, INHIBITOR, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.K.MUCKELBAUER REVDAT 2 06-MAR-24 5BPY 1 JRNL REMARK REVDAT 1 23-SEP-15 5BPY 0 JRNL AUTH Q.LIU,D.G.BATT,J.S.LIPPY,N.SURTI,A.J.TEBBEN,J.K.MUCKELBAUER, JRNL AUTH 2 L.CHEN,Y.AN,C.CHANG,M.POKROSS,Z.YANG,H.WANG,J.R.BURKE, JRNL AUTH 3 P.H.CARTER,J.A.TINO JRNL TITL DESIGN AND SYNTHESIS OF CARBAZOLE CARBOXAMIDES AS PROMISING JRNL TITL 2 INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) AND JANUS JRNL TITL 3 KINASE 2 (JAK2). JRNL REF BIOORG.MED.CHEM.LETT. V. 25 4265 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 26320619 JRNL DOI 10.1016/J.BMCL.2015.07.102 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 25205 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.810 REMARK 3 FREE R VALUE TEST SET COUNT : 1212 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2785 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2603 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2637 REMARK 3 BIN R VALUE (WORKING SET) : 0.2569 REMARK 3 BIN FREE R VALUE : 0.3277 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.31 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 148 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4080 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.52 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.46540 REMARK 3 B22 (A**2) : -1.47350 REMARK 3 B33 (A**2) : 5.93890 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.02850 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.327 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.355 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.227 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.359 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.230 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4267 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5770 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1496 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 95 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 660 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4267 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 530 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5002 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.08 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.85 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BPY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210297. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25301 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.03700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 34.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% MEPEG5K, PH 8.0, 298K, VAPOR REMARK 280 DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.58500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 393 REMARK 465 HIS A 394 REMARK 465 GLU A 658 REMARK 465 SER A 659 REMARK 465 GLY B 393 REMARK 465 HIS B 394 REMARK 465 GLU B 434 REMARK 465 LYS B 466 REMARK 465 GLN B 467 REMARK 465 ARG B 468 REMARK 465 PRO B 469 REMARK 465 LEU B 547 REMARK 465 ASP B 548 REMARK 465 ASP B 549 REMARK 465 GLU B 550 REMARK 465 TYR B 551 REMARK 465 THR B 552 REMARK 465 SER B 553 REMARK 465 SER B 554 REMARK 465 VAL B 555 REMARK 465 GLY B 556 REMARK 465 SER B 557 REMARK 465 GLU B 658 REMARK 465 SER B 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 400 CG CD CE NZ REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 GLN A 424 CG CD OE1 NE2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 ASN A 484 CG OD1 ND2 REMARK 470 MET A 489 CG SD CE REMARK 470 ARG A 490 CZ NH1 NH2 REMARK 470 ASP A 549 CG OD1 OD2 REMARK 470 LYS A 573 CG CD CE NZ REMARK 470 LYS A 595 CD CE NZ REMARK 470 SER A 604 OG REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 GLN A 612 OE1 NE2 REMARK 470 LYS B 400 CG CD CE NZ REMARK 470 LYS B 406 CE NZ REMARK 470 GLN B 412 CG CD OE1 NE2 REMARK 470 GLN B 424 CG CD OE1 NE2 REMARK 470 LYS B 433 CG CD CE NZ REMARK 470 MET B 437 CG SD CE REMARK 470 GLU B 444 CG CD OE1 OE2 REMARK 470 GLU B 445 CG CD OE1 OE2 REMARK 470 LYS B 447 CG CD CE NZ REMARK 470 GLU B 488 CG CD OE1 OE2 REMARK 470 MET B 489 CG SD CE REMARK 470 ARG B 490 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 492 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 546 CG1 CG2 REMARK 470 LYS B 573 CG CD CE NZ REMARK 470 LYS B 625 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 405 -147.21 -131.26 REMARK 500 LYS A 406 150.11 -44.27 REMARK 500 ARG A 520 -15.91 82.06 REMARK 500 ASP A 521 48.89 -142.90 REMARK 500 SER A 554 -2.16 -59.51 REMARK 500 ARG A 600 14.00 83.59 REMARK 500 GLN B 424 -37.17 -133.62 REMARK 500 ARG B 520 -14.54 81.23 REMARK 500 ASP B 521 49.18 -144.33 REMARK 500 PRO B 560 0.27 -62.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4UQ A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4UQ B 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5BQ0 RELATED DB: PDB DBREF 5BPY A 396 659 UNP Q06187 BTK_HUMAN 396 659 DBREF 5BPY B 396 659 UNP Q06187 BTK_HUMAN 396 659 SEQADV 5BPY GLY A 393 UNP Q06187 EXPRESSION TAG SEQADV 5BPY HIS A 394 UNP Q06187 EXPRESSION TAG SEQADV 5BPY MET A 395 UNP Q06187 EXPRESSION TAG SEQADV 5BPY GLY B 393 UNP Q06187 EXPRESSION TAG SEQADV 5BPY HIS B 394 UNP Q06187 EXPRESSION TAG SEQADV 5BPY MET B 395 UNP Q06187 EXPRESSION TAG SEQRES 1 A 267 GLY HIS MET GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 2 A 267 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 3 A 267 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 4 A 267 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 5 A 267 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 6 A 267 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 7 A 267 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 8 A 267 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 9 A 267 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 10 A 267 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 11 A 267 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 12 A 267 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 13 A 267 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 14 A 267 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 15 A 267 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 16 A 267 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 17 A 267 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 18 A 267 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 19 A 267 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 20 A 267 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 21 A 267 ASP VAL MET ASP GLU GLU SER SEQRES 1 B 267 GLY HIS MET GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 2 B 267 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 3 B 267 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 4 B 267 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 5 B 267 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 6 B 267 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 7 B 267 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 8 B 267 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 9 B 267 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 10 B 267 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 11 B 267 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 12 B 267 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 13 B 267 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 14 B 267 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 15 B 267 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 16 B 267 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 17 B 267 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 18 B 267 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 19 B 267 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 20 B 267 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 21 B 267 ASP VAL MET ASP GLU GLU SER HET 4UQ A4000 43 HET 4UQ B4000 43 HETNAM 4UQ 6-{(3R)-3-[(4-TERT-BUTYLBENZOYL)AMINO]PIPERIDIN-1-YL}- HETNAM 2 4UQ 2-{[4-(MORPHOLIN-4-YLCARBONYL)PHENYL]AMINO}PYRIDINE-3- HETNAM 3 4UQ CARBOXAMIDE FORMUL 3 4UQ 2(C33 H40 N6 O4) FORMUL 5 HOH *118(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 LEU A 482 GLU A 488 1 7 HELIX 4 AA4 GLN A 494 LYS A 515 1 22 HELIX 5 AA5 ALA A 523 ARG A 525 5 3 HELIX 6 AA6 LEU A 542 VAL A 546 5 5 HELIX 7 AA7 ASP A 548 SER A 553 1 6 HELIX 8 AA8 PRO A 560 SER A 564 5 5 HELIX 9 AA9 PRO A 565 SER A 572 1 8 HELIX 10 AB1 SER A 575 SER A 592 1 18 HELIX 11 AB2 THR A 602 GLN A 612 1 11 HELIX 12 AB3 SER A 623 CYS A 633 1 11 HELIX 13 AB4 LYS A 637 ARG A 641 5 5 HELIX 14 AB5 THR A 643 GLU A 657 1 15 HELIX 15 AB6 ASP B 398 LYS B 400 5 3 HELIX 16 AB7 SER B 438 ASN B 451 1 14 HELIX 17 AB8 LEU B 482 GLU B 488 1 7 HELIX 18 AB9 GLN B 494 LYS B 515 1 22 HELIX 19 AC1 ALA B 523 ARG B 525 5 3 HELIX 20 AC2 LEU B 542 VAL B 546 5 5 HELIX 21 AC3 LYS B 558 SER B 564 5 7 HELIX 22 AC4 PRO B 565 SER B 572 1 8 HELIX 23 AC5 SER B 575 SER B 592 1 18 HELIX 24 AC6 THR B 602 GLN B 612 1 11 HELIX 25 AC7 SER B 623 CYS B 633 1 11 HELIX 26 AC8 LYS B 637 ARG B 641 5 5 HELIX 27 AC9 THR B 643 GLU B 657 1 15 SHEET 1 AA1 5 LEU A 402 THR A 410 0 SHEET 2 AA1 5 VAL A 415 TRP A 421 -1 O VAL A 416 N LEU A 408 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 ILE A 470 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 3 GLY A 480 CYS A 481 0 SHEET 2 AA2 3 CYS A 527 VAL A 529 -1 O VAL A 529 N GLY A 480 SHEET 3 AA2 3 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 SHEET 1 AA3 5 LEU B 402 THR B 410 0 SHEET 2 AA3 5 VAL B 415 TRP B 421 -1 O VAL B 416 N LEU B 408 SHEET 3 AA3 5 TYR B 425 MET B 431 -1 O ILE B 429 N LYS B 417 SHEET 4 AA3 5 PHE B 471 GLU B 475 -1 O ILE B 472 N LYS B 430 SHEET 5 AA3 5 LEU B 460 CYS B 464 -1 N GLY B 462 O ILE B 473 SHEET 1 AA4 3 GLY B 480 CYS B 481 0 SHEET 2 AA4 3 CYS B 527 VAL B 529 -1 O VAL B 529 N GLY B 480 SHEET 3 AA4 3 VAL B 535 VAL B 537 -1 O LYS B 536 N LEU B 528 CISPEP 1 ARG A 468 PRO A 469 0 -3.33 SITE 1 AC1 12 LEU A 408 VAL A 416 ALA A 428 THR A 474 SITE 2 AC1 12 GLU A 475 TYR A 476 MET A 477 ALA A 478 SITE 3 AC1 12 ASN A 479 GLY A 480 CYS A 481 LEU A 528 SITE 1 AC2 12 VAL B 416 ALA B 428 THR B 474 GLU B 475 SITE 2 AC2 12 TYR B 476 MET B 477 ALA B 478 ASN B 479 SITE 3 AC2 12 GLY B 480 CYS B 481 ASN B 484 LEU B 528 CRYST1 64.110 45.170 99.200 90.00 93.91 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015598 0.000000 0.001066 0.00000 SCALE2 0.000000 0.022139 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010104 0.00000